Barrick to Report Full Year and Fourth Quarter 2025 Results on February 5
Rhea-AI Summary
Barrick (NYSE:B) will release its full year and fourth quarter 2025 results before markets open on Thursday, February 5, 2026 at 6:00 AM ET. Management will host a live webcast and presentation the same day at 11:00 AM ET followed by a question-and-answer session with analysts.
Presentation materials will be posted on the company website prior to the event and a replay will be available after the webcast. Registration is required to join the live webcast.
Positive
- None.
Negative
- None.
News Market Reaction
On the day this news was published, B declined 0.98%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Gold peers like WPM, FNV, AU, AEM, and KGC show gains of 2.13–3.48%, while B was up 4.37%, indicating stronger stock-specific strength than the peer group.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Dec 15 | Tech integration news | Positive | +0.6% | Kennametal-Hexagon integration to streamline digital tooling and machining workflows. |
| Dec 12 | Conference participation | Positive | -0.1% | Cereno Scientific planning investor and partner meetings at JPM Week and showcase. |
| Dec 11 | Industry ranking | Positive | +3.3% | ETQ named a Front Runner in LNS Research quality management software matrix. |
| Dec 08 | Drug access update | Positive | +2.2% | Leqembi added to China’s Commercial Insurance Innovative Drug List for broader coverage. |
| Dec 08 | FDA trial clearance | Positive | +2.2% | FDA cleared global Phase IIb trial of CS1 for pulmonary arterial hypertension. |
Across recent positive operational and regulatory updates, price reactions were usually positive, with one divergence on seemingly constructive news.
Recent news items tied to similarly tickered companies covered technology integrations, industry rankings, conference participation, and a major FDA trial clearance. Most positive announcements, such as ETQ’s "Front Runner" recognition and BioArctic’s Leqembi access update, saw gains of up to 3.33%. Only one constructive item, Cereno Scientific’s conference attendance, coincided with a small -0.14% move, showing mostly aligned reactions to favorable developments.
Market Pulse Summary
This announcement sets the timetable for Barrick’s full year and Q4 2025 results, with the release at 6:00 AM ET and webcast at 11:00 AM ET on February 5, 2026. Shares were trading near a 52-week high of 47.75 and above the 200-day MA, highlighting elevated expectations. Investors may focus on how reported results and guidance compare with this strong pre-announcement setup.
AI-generated analysis. Not financial advice.
TORONTO, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Barrick Mining Corporation (NYSE:B)(TSX:ABX) will release its full year and fourth quarter 2025 results before markets open on Thursday, February 5, 2026 at 6:00 AM ET. The management team will host a live webcast and presentation at 11:00 AM ET the same day, followed by a question-and-answer session with analysts.
Event Details – February 5, 2026
- Results release – 6:00 AM ET
- Live webcast and presentation – 11:00 AM ET
To join the webcast, please register at https://barrick-q4-2025.open-exchange.net. Presentation materials will be available on Barrick’s website prior to the event with a replay available soon after.
Investor Relations Contact
Barrick Mining Corporation
Cleve Rueckert, +1 775 397 5443
cleveland.rueckert@barrick.com
Media Contact
Brunswick Group
Carole Cable, +44 7974 982 458
barrick@brunswickgroup.com